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ABSTRACT
INTRODUCTION: The ketogenic diet (KD) is characterized by extremely high fat (F) intake and high car-
bohydrate (CH) restriction. It is currently used uncontrollably by the population to reduce body weight or 
body fat.
AIM: This article is an attempt to present the biochemical basis of KD and to summarize data regarding 
both the indications for its use as well as its undesirable effects and contraindications. Special attention is 
paid to the safety profile of KD.
MATERIALS AND METHODS: Articles, scientific books and publications related to low-carbohydrate 
diets and KD were searched in the PubMed database and Google Scholar. Articles published in the last de-
cade were included in the review. The search was conducted with a list of keywords: ketogenic diet, safety, 
obesity, health, mortality.
RESULTS: Studies of the effect of KD on obesity showed no difference in appetite control and weight loss 
compared to other isocaloric (but normal carbohydrate) diets. KDs have many contraindications and cre-
ate health risks. A meta-analysis of cohort studies finds a link between intake of CHs and overall mortali-
ty. The lowest risk of death is observed with the consumption of CHs, providing 50-55% of daily energy in-
take. Mortality is highest with an intake of CHs below 30%. A relatively higher risk of death was found when 
CHs on the menu were replaced with animal sources of fats and protein, and lower when replaced with veg-
etable fats.
CONCLUSION: When switching to KD, it is advisable to choose foods containing mostly unsaturated fats 
as a priority. It is desirable to avoid sources of saturated fatty acids and, in particular, hydrogenated oils 
rich in trans isomers of fatty acids. A healthier alternative to the classic KD could be the replacement of 
CHs with vegetable fats and proteins. This eating pattern can contribute to longevity and good health.
Keywords: ketogenic diet, safety, obesity, mortality
INTRODUCTION
The ketogenic diet (KD) is an alternative diet 
characterized by extremely high fat (F) intake and 
high carbohydrate (CH) restriction. The first KD 
models were developed in 1920 by Dr. R. Wilder 
(Mayo Clinic, USA) to treat type I diabetes and dif-
ficult-to-control epilepsy in children. A century ago, 
diet therapy in these patients was the only treatment 
because of the lack of effective drugs. Administra-
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following keywords: ketogenic diet, safety, obesity, 
health, mortality.
The Essence of KD
KD is an alternative diet with fat as the prima-
ry energy source. According to current recommen-
dations on healthy eating, carbohydrates should pro-
vide 45-60% of all calories, protein - 10-20%, and fat 
- up to 30% (3). In KD, this ratio is quite different: 
carbohydrates – 5% (up to 20%), proteins - 10%, fats 
- 70-85% (Table 1) (4,5). If the recommended dai-
ly energy intake of an individual is about 2000 kcal, 
then at KD his portion should bring in approximate-
ly 165 g of fat, 75 g of protein and only 20 g of carbo-
hydrates. The abundance of fat can be ensured both 
from vegetable sources (olive oil, avocado, coconut, 
palm, linseed, etc.) and animal products (fatty meat, 
organ meat, sausages, lard, bacon, butter, poultry fat, 
fatty fish and others).
A strict restriction on carbohydrates is achieved 
by excluding foods naturally rich in sugars from the 
menu:
  fruits (only berries are allowed, in very small 
quantities)
  starchy vegetables (carrots, turnips, potatoes, 
etc.)
  legumes
  cereals and pasta of all kinds
  milk (source of milk sugar - lactose)
  desserts (incl. containing sweeteners)
  alcohol
Nuts and a variety of vegetables (tomatoes, on-
ions, garlic, etc.) are restricted.
Currently, KDs are most commonly used by 
elite athletes and bodybuilders aiming to reduce 
their body fat rapidly, as well as by people with meta-
bolic disorders, overweight or obesity.
tion of KD leads to changes in brain metabolism and 
production of gamma-aminobutyric acid (GABA), 
which helps to reduce seizure symptoms in epilep-
sy. Between 1950 and 1990, KDs were left aside be-
cause of the availability of new anticonvulsant drugs 
and insulin. Interest in KD for the treatment of epi-
lepsy in children has been restored following a 1996 
meeting of the American Epilepsy Society. In 2008, 
an international consensus on the application of KD 
in neurological diseases, including epilepsy in chil-
dren, was adopted and later, updated in 2018 (1, 2). 
KDs have significant therapeutic potential and are 
currently successfully complementing treatment in:
  diseases of the nervous system (amyotrophic 
lateral sclerosis, multiple sclerosis, bipolar dis-
orders, some forms of epilepsy and autism, 
some brain tumours: glioblastoma, astrocyto-
ma, etc.)
  some rare genetic diseases (GLUT 1 syndrome, 
Rett syndrome, etc.)
  metabolic disorders (polycystic ovary syn-
drome, etc.)
Therapeutic effect is achieved by adhering to 
the KD for a minimum of 6-12 months.
AIM
This article aims to present the biochemical 
base of KD and to summarize data regarding both 
the indications for its use as well as its undesirable ef-
fects and contraindications. Special attention is paid 
to the safety profile of KD.
MATERIALS AND METHODS
Articles, scientific books and publications re-
lated to the low-carbohydrate diets and KD were 
searched in the PubMed database and Google Schol-
ar. Articles published in the last decade were includ-
ed in the review. The search was conducted with the 
Nutrient % of total energy intake  from following healthy eating
% of total energy intake  
from following KD
Carbohydrate 45-60 5 (up to 20 in less restrictive KD versions)
Protein 10-20 10
Fat 30-35 70-85
Table 1. Energy distribution of different nutrients (in %) in healthy eating and KD, adapted from (3,4,5).
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Biochemical Basis of KD 
In the course of its long evolution, the human 
body has adapted to use glucose as a major energy 
source. Many of our tissues can function by using 
fatty acids (e.g. muscles), but there are also glucose-
dependent organs and cells. This is especially true 
of the brain, kidneys, and erythrocytes. The human 
brain needs an average of 120 grams of glucose per 
day. In acute carbohydrate restriction, the brain re-
lies on glycogen stores. However, they run out quick-
ly - within 1-3 days. To ensure the normal function 
of the brain, which controls all other organs, the 
body triggers a process called gluconeogenesis (i.e., 
synthesis of glucose in the body from non-carbohy-
drate sources - fatty acids or amino acids, i.e. pro-
teins). For the first few days (3-5 days) after carbohy-
drate fasting, the blood sugar level (respectively, pro-
viding the brain with glucose) is maintained at the 
expense of protein degradation, i.e. of muscle mass. 
However, it is very disadvantageous for the human 
body to synthesize glucose from a protein and to lose 
valuable muscle tissue. Metabolic adaptation to pre-
serve muscle mass storage is turning to ketogenesis 
from fat (6,7,8). This process allows a large part of the 
body’s energy expenditure to be covered by the ke-
tone bodies (ketones) obtained from the breakdown 
of fat stores (adipose tissue). Ketones are water-sol-
uble molecules produced in the liver by fatty acids. 
In carbohydrate starvation, they cover part of the 
brain’s energy needs. When the blood ketones reach 
a concentration >2 mmol/L a condition known as ke-
tosis occurs. In ketosis, the body relies primarily on 
fat as an energy source. Ketogenesis arose during the 
evolution due to episodic starvation in the nomad-
ic period of human history. The enzyme that breaks 
down fat into free fatty acids and ketones is called 
hormone-sensitive lipase, and is only active if insu-
lin levels are low. This means that the import of car-
bohydrates must stop in order to start ketogenesis. A 
healthy person often falls into ketosis spontaneously 
- e.g. after prolonged sleep (because he did not eat), 
after heavy training or exercise without nutrition-
al support, after prolonged fasting on various occa-
sions, etc. Plasma concentrations of ketones at vari-
ous conditions are presented in Table 2.
How Do Ketones Work?
Because they are relatively small and water-sol-
uble molecules, ketones cross the blood-brain barri-
er and reach two very important centres in the cere-
bral cortex: the centre of appetite and the centre of 
euphoria. In this way, ketones affect the levels of the 
hormones ghrelin and leptin (regulators of appetite 
and satiety). They suppress appetite, improve hun-
ger control and reduce cravings for sugary foods. As 
a result, energy intake and body weight are reduced 
without significantly affecting muscle mass.
Effect of KD on Overweight and Obesity
Currently, KDs are uncontrollably used for 
overweight and obese people without considering 
the health risks of carbohydrate starvation. There is 
no evidence yet that, in the long run, KDs are eas-
ier to follow and more successful than other alter-
native eating patterns in overweight people (9). KDs 
may be an option for some people who have had dif-
ficulties losing weight with other methods. Howev-
er, the exact ratio of fats, proteins, and carbohydrates 
that are needed to achieve the goals are different in 
different individuals due to their unique genome and 
body composition. A meta-analysis of 13 random-
ized controlled trials (lasting >12 months) compares 
two isocaloric diets - KD (very low carbohydrate 
diet) and a low-fat diet. The results are similar - the 
average weight loss with KD is only 2 pounds more 
over a 12-month period. In the second year, the re-
sults are countervailed (10). An analysis of 26 short-
term studies (4-12 weeks) compares appetite control 
by KD and a low-fat diet (isocaloric), before and after 
Plasma ketone concentration 
(mmol / L)
Mixed Eating 0.1
Fasting 2-3 days 1.0
Fasting for 1 week 5
Ketogenic diet 5-6
Fasting for 3-4 weeks 6-8
Ketoacidosis 8+
Diabetic ketoacidosis Up to 25
Table 2. Concentration of ketone bodies in the blood 
in various physiological and pathological conditions, 
adapted from (6,7,8).
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the nutritional intervention. The results are similar 
in terms of appetite and weight loss (11).
Safety Profile of KD
A number of common side effects due to ex-
treme restriction of CHs have been described: fa-
tigue (mental and muscular), muscle cramps, nau-
sea, dizziness, dysthymia (apathy, depression, ag-
gression), irritability, headache, cognitive impair-
ment (disorders of memory, concentration, brain 
fog), constipation and more (12,13,14,15). 
A number of studies have looked at the rela-
tionship between CH intake and overall mortali-
ty. One of the most extensive studies in this area is 
ARIC (Atherosclerosis Risk in Communities) (16,17). 
It investigates the link between average CH con-
sumption and the risk of death over a 25-year period. 
Eating habits of 15428 people aged 45-64 years, all 
without extreme cases of daily energy intake (within 
600 - 4200 kcal for men and 500 - 3600 kcal for wom-
en), have been studied. After adjusting for risk fac-
tors (age, gender, ethnicity, BMI, energy intake, edu-
cation, physical activity, income, smoking, diabetes 
mellitus, etc.), the results show a statistically signifi-
cant, non-linear U-shaped relationship (p <0.001) be-
tween risk from death and eating CH. The lowest risk 
is observed when the consumption of CHs is provid-
ing 50-55% of daily energy intake. Mortality is high-
est when CH consumption is less than 30% and grad-
ually increases when CH consumption exceeds 60%. 
A relatively higher risk of death was found when CHs 
on the menu were replaced with animal fats and pro-
tein, and lower when replaced with vegetable fats. 
The conclusion is that there are significant differ-
ences in the average predicted life expectancy based 
on CH intake. A meta-analysis including 12 publica-
tions of studies in North America, Europe, Asia, as 
well as international cohorts in recent years (includ-
ing a total of 432 179 people and 40 181 deaths - 9.3% 
of the total group followed) confirms ARIC results 
(18,19,20,21,22,23,24,25).
The most significant health risks in strict com-
pliance with KD are: 
  in children: slow growth (26), frequent acidosis, 
increased incidence of infections (by 2-4%, due 
to impaired neutrophil function) (27);
  problems with the gastrointestinal tract: bad 
breath (due to ketonaemia), reflux, biliary dys-
kinesia, constipation, pancreatitis, etc.
  in some human populations, due to genetic 
polymorphism, there is a reduced tolerance to 
high fat intake with the consequence of great-
ly elevated triglycerides and cholesterol (dys-
lipidaemia) and increased cardiovascular risk 
(19,22)
  worsening and exacerbation of kidney diseases 
(renal failure, gout, etc.), liver conditions, bone 
problems (including fracture healing and osteo-
porosis, (28);
  tendency for hypoglycaemia
  electrolyte imbalance affecting potassium, cal-
cium, and magnesium, which is manifested by 
painful cramps, nausea, dizziness
It is absolutely contraindicated for KD to be 
followed by children and adolescents; women dur-
ing pregnancy and lactation, women with second-
ary amenorrhea and reproductive problems; indi-
viduals with BMI <25; individuals with eating dis-
orders (anorexia, bulimia, etc.), with alcoholism or 
other addictions; mental illness (psychosis); por-
phyria and some congenital enzyme deficits; renal or 
hepatic insufficiency (including active chronic hep-
atitis), gout; some endocrine disorders: type 1 dia-
betes, hyperthyroidism, Cushing’s syndrome; hae-
matological diseases; fresh myocardial infarction (6 
months ago), unstable angina, heart failure, vascular 
incident; progressive inflammatory and malignant 
diseases (29,30,31,32). Relative contraindications to 
KD are kidney and gall bladder stones and treatment 
with diuretics (risk of developing hypokalaemia and 
heart rhythm disorders).
Several issues of increased difficulty are 
raised in relation to following a KD. First of all, is 
the risk for long-term health and safety (over 1 year). 
Another serious question is whether the side effects 
do or do not outweigh the potential benefits in poly-
morphic patients. Obese individuals have a number 
of accompanying disorders, some of which can wors-
en and exacerbate during ketosis. There is a serious 
risk of following a KD in patients with disorders of 
protein and lipid metabolism (kidney, liver, pancre-
atic) and induction into ketosis in these patients can 
be life-threatening. Last but not least is the question 
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of the selection of fat sources in KD and the fatty acid 
profile of the food. It is very important whether 70-
80% of the calories in the daily menu will come from 
mostly saturated fat or at the expense of monounsat-
urated and polyunsaturated fat. With the develop-
ment of nutrigenomics and nutrigenetics, it has be-
come clear that there is a genetic polymorphism in 
the human population regarding the metabolism of 
various fatty acids with unpredictable consequences 
for atherogenic risk.
Instead of a Recommendation
When switching to KD, it is advisable to choose, 
as a matter of priority, foods containing mostly un-
saturated fats: fish, nuts, seeds, olive oil, avocado, 
and poultry. It is desirable to avoid sources of satu-
rated fatty acids, especially unconventional for the 
geographic area such as coconut and palm oils. It is 
absolutely inappropriate and dangerous for health 
to include hydrogenated oils rich in trans-isomers 
of fatty acids. A healthier alternative to classic KD 
as a weight loss approach could be to replace CHs 
with mostly vegetable fats and proteins. This eat-
ing pattern can be considered as a long-term strat-
egy to achieve active longevity and preserved health 
(33). KD may be an alternative for some people who 
have had difficulty achieving their health or weight 
goals through other methods. However, the exact ra-
tio of fat, CH and protein will vary from one individ-
ual to another due to the specific set of genes and fea-
tures in body composition. Therefore, if a person de-
cides to start KD, it is recommended that they con-
sult a dietician to monitor any biochemical changes 
after starting the diet. The doctor will create a nu-
tritional plan that is tailored to the health status and 
physiological characteristics and will give adequate 
instructions for reintroducing the carbohydrates (in 
the appropriate quantitative and qualitative compo-
sition) after reaching the goals. This will minimize 
the health risks of prolonged ketosis. Potential side 
effects of KD can be limited by monitoring the pa-
tient during the initiation and maintenance of KD 
(34). The side effects of KD are manageable , howev-
er, it is important for the clinician to recognize them 
and to make changes of nutrition and health assess-
ment. The diet could have/has a therapeutic potential 
on different diseases in clinical practice. The present 
review also questions the side effects when the diet is 
not under medical supervision.
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